Author:
Hanaei Sara,Arrieta Víctor Andrés,Sonabend Adam M.
Publisher
Springer International Publishing
Reference230 articles.
1. Davis FG, Freels S, Grutsch J, Barlas S, Brem S. Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973–1991. J Neurosurg. 1998;88:1–10.
2. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10:459–66.
3. Parney IF. Basic concepts in glioma immunology. In: Yamanaka R, editor. Glioma. New York: Springer; 2012. p. 42–52.
4. Harling-Berg C, Hallett J, Park J, Knopf P. Hierarchy of immune responses to antigen in the normal brain. In: Protective and pathological immune responses in the CNS. Berlin/New York: Springer; 2002. p. 1–22.
5. Gehrmann J, Banati R, Wiessnert C, Hossmann KA, Kreutzberg G. Reactive microglia in cerebral ischaemia: an early mediator of tissue damage? Neuropathol Appl Neurobiol. 1995;21:277–89.